Cited in boardrooms, legal proceedings & government briefings since 2017
Market structure, patient access and the regulatory outlook for the UK's medical sector.
Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.
Trusted by teams at
Market structure, patient access and the regulatory outlook for the UK's medical sector. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.
1
market covered
40+
pages of analysis
2025
published
Sales estimates and five-year forecasts across the market, built from PP's proprietary sizing models.
Where the rules stand, what changes next, and what each move means commercially.
Every figure numbered and sourced — modelled, checked and signed off by PP's analysts.
Investors & analysts
Defensible sizing and forecasts to underwrite the thesis.
Corporate strategy & FMCG
Opportunity sizing and entry routes across key markets.
